Elaine M. Walsh

Also affiliated with MedStar Georgetown University Hospital

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 6 papers. Top paper: “Management of hormone receptor-positive, HER2-negative early breast cancer”.

Management of hormone receptor-positive, HER2-negative early breast cancer

Seminars in Oncology(2020)10.1053/j.seminoncol.2020.05.010

N/A

0DataRank · unranked

54 citations

Karen L. Smith, Vered Stearns, Elaine M. Walsh

Olaparib Use in Patients With Metastatic Breast Cancer Harboring Somatic BRCA1/2 Mutations or Mutations in Non-BRCA1/2, DNA Damage Repair Genes

Clinical Breast Cancer(2021)10.1016/j.clbc.2021.12.007

N/A

0DataRank · unranked

15 citations

Neha Mangini, John H. Fetting, Deborah K. Armstrong, Isaac S. Chan, Roisín M. Connolly +13 more

Accelerating drug development in breast cancer: New frontiers for ER inhibition

Cancer Treatment Reviews(2022)10.1016/j.ctrv.2022.102432

N/A

0DataRank · unranked

52 citations

Elaine M. Walsh, Jacqueline J. Tao, Sarat Chandarlapaty, Komal Jhaveri, Emanuela Ferraro

Adjuvant enzalutamide for the treatment of early-stage androgen-receptor positive, triple-negative breast cancer: a feasibility study

Breast Cancer Research and Treatment(2022)10.1007/s10549-022-06669-2

N/A

0DataRank · unranked

17 citations

Ayca Gucalp, Sujata Patil, Marcia Edelweiss, Dara S. Ross, Pedram Razavi +17 more

HER2 persistence after treatment with T-DXd in breast and gastrointestinal cancers.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.1052

N/A

0DataRank · unranked

6 citations

Fresia Pareja, Komal Jhaveri, Elaine M. Walsh, Geoffrey Y. Ku, Steven B. Maron +7 more

ETHAN: A phase II study comparing different endocrine therapies for male breast cancer.

Journal of Clinical Oncology(2024)10.1200/jco.2024.42.16_suppl.tps632

N/A

0DataRank · unranked

2 citations

Kathryn J. Ruddy, Naim U. Rashid, Jasmine Sukumar, Sharon H. Giordano, Gaorav P. Gupta +10 more